中药蛴螬多肽Probrelin抗白色念珠菌活性研究
作者:
基金项目:

国家自然科学基金(81703475);河南省大学生创新创业训练计划(202010464056)


Activity of the antimicrobial peptide probrelin from traditional Chinese medicine grub against Candida albicans
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [34]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    [目的] 研究蛴螬多肽Probrelin对白色念珠菌的抗菌活性。[方法] 采用肉汤稀释法测定蛴螬多肽Probrelin对正常菌株及临床耐药菌株的最小抑菌浓度,同时结合平板计数法测定最小杀真菌浓度;通过不同浓度多肽处理后经平板计数绘制时间-杀菌动力学曲线;通过PI吸收实验检测多肽对白色念珠菌细胞膜完整性的影响;通过核酸阻滞实验检测多肽与核酸间是否具有结合作用;通过扫描电子显微镜检测多肽对白色念珠菌形态的影响;通过结晶紫染色法检测多肽对生物膜生成及成熟生物膜的影响;通过显微镜观察多肽对白色念珠菌菌丝形成的影响;通过棋盘法检测多肽与抗真菌药物间的相互效应;通过小鼠皮下感染模型检测多肽在生理条件下的抗白色念珠菌活性。[结果] 蛴螬多肽Probrelin对正常菌株及临床耐药菌株的最小抑菌浓度均为100 μg/mL,最小杀真菌浓度为100-200 μg/mL,且对白色念珠菌的杀菌动力学具有时间和浓度依赖性;该多肽以浓度依赖性的方式影响白色念珠菌细胞膜的完整性,并通过破坏白色念珠菌细胞壁的结构影响其形态,但与核酸间不具有结合作用;该多肽既可抑制白色念珠菌生物膜的形成,又可清除成熟生物膜,同时还可抑制白色念珠菌菌丝的形成;该多肽与抗真菌药物Clotrimazole间具有协同效应;在小鼠皮下感染模型中,该多肽可以有效杀灭白色念珠菌,进而抑制感染。[结论] 蛴螬多肽Probrelin对白色念珠菌具有良好的抑制杀灭活性,可以作为新的药物分子或模板分子用于抗白色念珠菌药物的研发。

    Abstract:

    [Objective] To investigate the activity of the peptide probrelin from traditional Chinese medicine grub against Candida albicans. [Methods] The broth microdilution method was used to determine the MIC of probrelin against normal and clinical resistant strains of C. albicans, and the MFC were determined by plate count method. Time-kill curves were drawn by plate counting after treatment with different concentrations of probrelin. The influences of probrelin on the integrity of the cell membrane and morphology of C. albicans were evaluated by PI absorption experiment and scanning electron microscope, respectively. The binding effect between probrelin and nucleic acid was evaluated by DNA gel retardation assay. Crystal violet staining method was used to evaluate the influences of probrelin on the formation of biofilm and mature biofilm of C. albicans. And the influences of probrelin on the hyphae formation of C. albicans were also tested. Checkerboard method was used to determine the interaction between probrelin and antifungal drugs. And a mouse subcutaneous infection model was used to tested the activity of probrelin against C. albicans under physiological conditions. [Results] The MICs of probrelin against normal and clinical resistant strains of C. albicans were 100 μg/mL, and the MFCs were 100-200 μg/mL. Probrelin showed time-and concentration-dependent antifungal activity against C. albicans, as well as on the integrity of the cell membrane, and could destroy the cell wall, but did not bind with nucleic acids. Probrelin not only inhibited the formation of the biofilm of C. albicans, but also disrupted the mature biofilm, and could also inhibit the hyphae formation. Furthermore, probrelin showed synergistic effect with the antifungal drug Clotrimazole, and could effectively clear C. albicans cells in the mouse subcutaneous infection model. [Conclusion] Probrelin showed good activity against C. albicans, and had the potential for the development of anti-C. albicans drugs.

    参考文献
    [1] Dadar M, Tiwari R, Karthik K, Chakraborty S, Shahali Y, Dhama K. Candida albicans-Biology, molecular characterization, pathogenicity, and advances in diagnosis and control-An update. Microbial Pathogenesis, 2018, 117:128-138.
    [2] Costa-De-oliveira S, Rodrigues AG. Candida albicans antifungal resistance and tolerance in bloodstream infections:the triad yeast-host-antifungal. Microorganisms, 2020, 8(2):154.
    [3] Wan JF, Tang CP, Shen ZB, Jiang T. Research status of natural compounds combine with antifungal agents against drug-resistent Candida albicans. China Journal of Chinese Materia Medica, 2014, 39(1):28-33. (in Chinese) 万江帆, 唐春萍, 沈志滨, 江涛. 中药单体联用抗真菌药物抗耐药白色念珠菌的研究现状. 中国中药杂志, 2014, 39(1):28-33.
    [4] Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clinical Microbiology Reviews, 2006, 19(3):491-511.
    [5] Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends in Biotechnology, 2011, 29(9):464-472.
    [6] Mahlapuu M, Håkansson J, Ringstad L, Björn C. Antimicrobial peptides:an emerging category of therapeutic agents. Frontiers in Cellular and Infection Microbiology, 2016, 6:194.
    [7] Hancock RE. Cationic peptides:effectors in innate immunity and novel antimicrobials. The Lancet Infectious Diseases, 2001, 1(3):156-164.
    [8] Chung PY, Khanum R. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. Journal of Microbiology, Immunology and Infection, 2017, 50(4):405-410.
    [9] Fox JL. Antimicrobial peptides stage a comeback. Nature Biotechnology, 2013, 31(5):379-382.
    [10] Zhao Y, Li ZG, Wang LH, Sun YT, Zhao L, Zan K. Quality standard and research progress of traditional Chinese medicine Holotrichia diomphalia larvae. Chinese Journal of Drug Evaluation, 2020, 37(4):257-261, 281. (in Chinese) 赵艳, 李正刚, 王路宏, 孙艳涛, 赵磊, 昝珂. 中药蛴螬的质量标准及研究进展. 中国药物评价, 2020, 37(4):257-261, 281.
    [11] Wang C, Yu YG, Zhang Q, Yu XX, Liang ZM. Preparation and stability studies of grub antimicrobial peptides. Guangdong Agricultural Sciences, 2018, 45(2):116-122. (in Chinese) 王成, 余以刚, 张青, 余祥雄, 梁泽明. 蛴螬抗菌肽的制备及其稳定性研究. 广东农业科学, 2018, 45(2):116-122.
    [12] Li ZJ, Meng MM, Li SS, Deng B. The transcriptome analysis of Protaetia brevitarsis Lewis larvae. PLoS ONE, 2019, 14(3):e0214001.
    [13] Guilhelmelli F, Vilela N, Smidt KS, de Oliveira MA, da Cunha Morales Álvares A, Rigonatto MC, da Silva Costa PH, Tavares AH, de Freitas SM, Nicola AM, Franco OL, Derengowski LD, Schwartz EF, Mortari MR, Bocca AL, Albuquerque P, Silva-Pereira I. Activity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans biofilms. Frontiers in Microbiology, 2016, 7:1844.
    [14] Cassone M, Otvos Jr L. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Review of Anti-Infective Therapy, 2010, 8(6):703-716.
    [15] Youn C, Archer NK, Miller LS. Research techniques made simple:mouse bacterial skin infection models for immunity research. Journal of Investigative Dermatology, 2020, 140(8):1488-1497.e1.
    [16] Brion LP, Uko SE, Goldman DL. Risk of resistance associated with fluconazole prophylaxis:Systematic review. Journal of Infection, 2007, 54(6):521-529.
    [17] Liu SY, Hou YL, Chen X, Gao Y, Li H, Sun SJ. Combination of fluconazole with non-antifungal agents:a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. International Journal of Antimicrobial Agents, 2014, 43(5):395-402.
    [18] Jin L, Bai X, Luan N, Yao H, Zhang Z, Liu W, et al. A designed tryptophan- and lysine/arginine-rich antimicrobial peptide with therapeutic potential for clinical antibiotic-resistant Candida albicans vaginitis. Journal of Medicinal Chemistry, 2016, 59(5):1791-1799.
    [19] Fjell CD, Hiss JA, Hancock REW, Schneider G. Designing antimicrobial peptides:form follows function. Nature Reviews Drug Discovery, 2012, 11(1):37-51.
    [20] Ma HL, Zhao XY, Yang LB, Su PP, Fu P, Peng J, Yang N, Guo G. Antimicrobial peptide AMP-17 affects Candida albicans by disrupting its cell wall and cell membrane integrity. Infection and Drug Resistance, 2020, 13:2509-2520.
    [21] de Aguiar FLL, Santos NC, de Paula Cavalcante CS, Andreu D, Baptista GR, Gonçalves S. Antibiofilm activity on Candida albicans and mechanism of action on biomembrane models of the antimicrobial peptide ctn[15-34]. International Journal of Molecular Sciences, 2020, 21(21):8339.
    [22] Li LR, Song FX, Sun J, Tian X, Xia SF, Le GW. Membrane damage as first and DNA as the secondary target for anti-candidal activity of antimicrobial peptide P7 derived from cell-penetrating peptide ppTG20 against Candida albicans. Journal of Peptide Science, 2016, 22(6):427-433.
    [23] Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II:buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochemical and Biophysical Research Communications, 1998, 244(1):253-257.
    [24] Li ZJ, Xu XB, Meng LX, Zhang Q, Cao LY, Li WX, Wu YL, Cao ZJ. Hp1404, a new antimicrobial peptide from the scorpion Heterometrus petersii. PLoS ONE, 2014, 9(5):e97539.
    [25] Li LR, Sun J, Xia SF, Tian X, Cheserek MJ, Le GW. Mechanism of antifungal activity of antimicrobial peptide APP, a cell-penetrating peptide derivative, against Candida albicans:intracellular DNA binding and cell cycle arrest. Applied Microbiology and Biotechnology, 2016, 100(7):3245-3253.
    [26] Tsui C, Kong EF, Jabra-Rizk MA. Pathogenesis of Candida albicans biofilm. Pathogens and Disease, 2016, 74(4):ftw018.
    [27] Mathé L, Van Dijck P. Recent insights into Candida albicans biofilm resistance mechanisms. Current Genetics, 2013, 59(4):251-264.
    [28] Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm development. Nature Reviews Microbiology, 2011, 9(2):109-118.
    [29] Wang KR, Yan JX, Dang W, Xie JQ, Yan B, Yan WJ, Sun MY, Zhang BZ, Ma MX, Zhao YY, Jia FJ, Zhu RR, Chen W, Wang R. Dual antifungal properties of cationic antimicrobial peptides polybia-MPI:Membrane integrity disruption and inhibition of biofilm formation. Peptides, 2014, 56:22-29.
    [30] Belmadani A, Semlali A, Rouabhia M. Dermaseptin-S1 decreases Candida albicans growth, biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes. Journal of Applied Microbiology, 2018, 125(1):72-83.
    [31] Pereira R, dos Santos Fontenelle RO, de Brito EHS, de Morais SM. Biofilm of Candida albicans:formation, regulation and resistance. Journal of Applied Microbiology, 2021, 131(1):11-22.
    [32] Spitzer M, Robbins N, Wright GD. Combinatorial strategies for combating invasive fungal infections. Virulence, 2017, 8(2):169-185.
    [33] Wang AP, Wang RJ, Li RY. New progress of antifungal agents. Dermatology Bulletin, 2017, 34(5):540-550, 4. (in Chinese) 王爱平, 王若珺, 李若瑜. 抗真菌药物新进展. 皮肤科学通报, 2017, 34(5):540-550, 4.
    [34] Fang JY, Tang KW, Yang SH, Alalaiwe A, Yang YC, Tseng CH, Yang SC. Synthetic naphthofuranquinone derivatives are effective in eliminating drug-resistant Candida albicans in hyphal, biofilm, and intracellular forms:an application for skin-infection treatment. Frontiers in Microbiology, 2020, 11:2053.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

胡平,赵卓冉,袁亚萍,李莎莎,景晓愿,李钟杰. 中药蛴螬多肽Probrelin抗白色念珠菌活性研究[J]. 微生物学报, 2021, 61(11): 3619-3630

复制
分享
文章指标
  • 点击次数:390
  • 下载次数: 1241
  • HTML阅读次数: 1493
  • 引用次数: 0
历史
  • 收稿日期:2021-02-06
  • 最后修改日期:2021-04-13
  • 在线发布日期: 2021-11-04
文章二维码